Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary

Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary

Collection:
Health Policy and Services Research
Contributor(s):
Institute for Clinical and Economic Review, issuing body.
Midwest Comparative Effectiveness Public Advisory Council, issuing body.
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
Language(s):
English
Format:
Text
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (vi, ES22, 109 pages))
Illustrations:
Illustrations
NLM Unique ID:
101723893 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101723893